Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LTGO · NASDAQ · Pharmaceutical Preparations · No 10-K yet
$13.00−0.24 (−1.81%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Latigo Biotherapeutics (LTGO) · oqro.io/stocks/LTGO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Kush Parmar now owns 11% of LTGO as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Blue Owl Capital Holdings LP now owns 5.4% of LTGO as a passive investorSource5%+ stake · Stake as of Sep 3, 2026 · Filed Nov 6, 2026
AI Biotechnology LLC cut its LTGO stake below 5% (4.8%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 29, 2026
Dr. Beth C. Seidenberg now owns 19.9% of LTGO as a passive investorSource